Syncona Portfolio Ltd

Overview

• HeadquartersY7¹

See how the biggest companies compare on our leaderboards

Corporate structure

Syncona Portfolio Ltd sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.

Filings

22 filings to the SEC since October 2021: 22 other. The latest 20:

1. Aug 27, 2026N-PX EDGAR
2. Aug 7, 202613F-HR EDGAR
3. May 14, 202613F-HR EDGAR
4. Feb 5, 202613F-HR EDGAR
5. Nov 6, 202513F-HR EDGAR
6. Aug 21, 2025N-PX EDGAR
7. Aug 7, 202513F-HR EDGAR
8. May 7, 202513F-HR EDGAR
9. Feb 6, 202513F-HR EDGAR
10. Nov 14, 202413F-HR EDGAR
11. Aug 23, 2024N-PX EDGAR
12. Aug 13, 202413F-HR EDGAR
13. May 7, 202413F-HR EDGAR
14. Feb 1, 202413F-HR EDGAR
15. Nov 1, 202313F-HR EDGAR
16. Jul 27, 202313F-HR EDGAR
17. May 12, 202313F-HR EDGAR
18. Feb 14, 202313F-HR EDGAR
19. Nov 4, 202213F-HR EDGAR
20. Aug 10, 202213F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Syncona Portfolio Ltd has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

• Autolus TherapeuticsSCHEDULE 13G/A Feb 11, 2022 to May 7, 2025²
• Freeline Therapeutics Holdings plcSC 13D/A Feb 11, 2022 to Feb 22, 2024³
• Achilles Therapeutics plcSC 13G/A Feb 11, 2022 to Feb 13, 2024⁴